CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoVIGNA, Elisa
Dettaglio
VIGNA, Elisa
ONCOLOGIA
Pubblicazioni
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. | 1992 | HARTMANN G ;NALDINI L ;WEIDNER KM ;SACHS M ;VIGNA E ;COMOGLIO PM ;BIRCHMEIER W |
| 2 | A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity. | 2013 | Olwill SA;Joffroy C;Gille H;Vigna E;Matschiner G;Allersdorfer A;Lunde BM;Jaworski J;Burrows JF;Chiriaco C;Christian HJ;Hülsmeyer M;Trentmann S;Jensen K;Hohlbaum AM;Audoly L |
| 3 | "Active" cancer immunotherapy by anti-Met antibody gene transfer | 2008 | Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM |
| 4 | Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes | 2015 | Valentina Sala;Simona Gallo;Stefano Gatti;Elisa Vigna;Antonio Ponzetto;Tiziana Crepaldi |
| 5 | Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products | 2007 | COMOGLIO Paolo Maria; VIGNA Elisa; GIORDANO Silvia |
| 6 | Antibody Fragments, Compositions And Uses Thereof - granted patent (USA) | 2019 | Elisa Vigna; Paolo Michieli; Paolo Maria Comoglio |
| 7 | Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. | 1995 | NALDINI L ;VIGNA E ;BARDELLI A ;FOLLENZI A ;GALIMI F ;COMOGLIO PM |
| 8 | Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib | 2016 | Sala, Valentina; Gallo, Simona; Gatti, Stefano; Medico, Enzo; Vigna, Elisa; Cantarella, Daniela; Fontani, Lara; Natale, Massimo; Cimino, James; Morello, Mara; Comoglio, Paolo Maria; Ponzetto, Antonio; Crepaldi, Tiziana |
| 9 | CD44v6 as innovative sarcoma target for CAR-redirected CIK cells | 2018 | Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D. |
| 10 | Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. | 2005 | Amendola M;Venneri MA;Biffi A;Vigna E;Naldini L |
| 11 | Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody | 2016 | Cignetto, Simona; Modica, Chiara; Chiriaco, Cristina; Fontani, Lara; Milla, Paola; Michieli, Paolo; Comoglio, Paolo M.; Vigna, Elisa |
| 12 | Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector. | 2005 | Vigna E;Amendola M;Benedicenti F;Simmons AD;Follenzi A;Naldini L |
| 13 | Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. | 1992 | NALDINI L ;TAMAGNONE L ;VIGNA E ;SACHS M ;HARTMANN G ;BIRCHMEIER W ;DAIKUHARA Y ;TSUBOUCHI H ;BLASI F ;COMOGLIO PM |
| 14 | Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. | 1991 | NALDINI L ;VIGNA E ;NARSIMHAN RP ;GAUDINO G ;ZARNEGAR R ;MICHALOPOULOS GK ;COMOGLIO PM |
| 15 | Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene. | 1994 | VIGNA E ;NALDINI L ;TAMAGNONE L ;LONGATI P ;BARDELLI A ;MAINA F ;PONZETTO C ;COMOGLIO PM |
| 16 | Hepatocyte growth factor is a regulator of monocyte-macrophage function | 2001 | F. GALIMI; E. COTTONE; E. VIGNA; N. ARENA; C. BOCCACCIO; S. GIORDANO; L. NALDINI; P. COMOGLIO |
| 17 | Human cord blood CD34+ progenitor cells acquire functional cardiac properties through a cell fusion process. | 2011 | Avitabile D;Crespi A;Brioschi C;Parente V;Toietta G;Devanna P;Baruscotti M;Truffa S;Scavone A;Rusconi F;Biondi A;D'Alessandra Y;Vigna E;Difrancesco D;Pesce M;Capogrossi MC;Barbuti A |
| 18 | Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. | 1991 | FERRACINI R ;LONGATI P ;NALDINI L ;VIGNA E ;COMOGLIO PM |
| 19 | Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET. | 1999 | E. VIGNA; D. GRAMAGLIA; P. LONGATI; A. BARDELLI; P.M. COMOGLIO |
| 20 | Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. | 2015 | Sala, V.; Gallo, S.; Gatti, S.; Medico, E.; Vigna, E.; Cantarella, D.; Fontani, L.; Natale, M.; Morello, M.; Ponzetto, A.; Crepaldi, T. |
Copyright © 2020